• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广泛耐药铜绿假单胞菌感染的流行病学和危险因素。

Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections.

机构信息

Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

PLoS One. 2018 Feb 22;13(2):e0193431. doi: 10.1371/journal.pone.0193431. eCollection 2018.

DOI:10.1371/journal.pone.0193431
PMID:29470531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5823452/
Abstract

BACKGROUND

The incidence of nosocomial infections from extensively drug-resistant Pseudomonas aeruginosa (XDR-PA) has been increasing worldwide. We investigated the prevalence and factors associated with XDR-PA infections, including the factors that predict mortality.

METHODS

We retrospectively studied a cohort of adult, hospitalized patients with P. aeruginosa (PA) infections between April and December 2014.

RESULTS

Of the 255 patients with PA infections, 56 (22%) were due to XDR-PA, 32 (12.5%) to multidrug resistant Pseudomonas aeruginosa (MDR-PA), and 167 (65.5%) to non-MDR PA. Receiving total parenteral nutrition (adjusted OR [aOR] 6.21; 95% CI 1.05-36.70), prior carbapenem use (aOR 4.88; 95% CI 2.36-10.08), and prior fluoroquinolone use (aOR 3.38; 95% CI 1.44-7.97) were independently associated with the XDR-PA infections. All XDR-PA remained susceptible to colistin. Factors associated with mortality attributable to the infections were the presence of sepsis/septic shock (aOR 11.60; 95% CI 4.66-28.82), admission to a medical department (aOR 4.67; 95% CI 1.81-12.06), receiving a central venous catheter (aOR 3.78; 95% CI 1.50-9.57), and XDR-PA infection (aOR 2.73; 95% CI 1.05-7.08).

CONCLUSION

The prevalence of XDR-PA infections represented almost a quarter of Pseudomonas aeruginosa hospital-acquired infections and rendered a higher mortality. The prompt administration of an appropriate empirical antibiotic should be considered when an XDR-PA infection is suspected.

摘要

背景

广泛耐药铜绿假单胞菌(XDR-PA)引起的医院感染发病率在全球范围内呈上升趋势。我们调查了 XDR-PA 感染的流行情况和相关因素,包括预测死亡率的因素。

方法

我们回顾性研究了 2014 年 4 月至 12 月期间住院的铜绿假单胞菌(PA)感染成年患者队列。

结果

在 255 例 PA 感染患者中,56 例(22%)为 XDR-PA,32 例(12.5%)为多药耐药铜绿假单胞菌(MDR-PA),167 例(65.5%)为非 MDR-PA。接受全胃肠外营养(调整后的比值比 [aOR] 6.21;95%可信区间 1.05-36.70)、碳青霉烯类药物使用史(aOR 4.88;95%可信区间 2.36-10.08)和氟喹诺酮类药物使用史(aOR 3.38;95%可信区间 1.44-7.97)与 XDR-PA 感染独立相关。所有 XDR-PA 对黏菌素仍保持敏感。感染相关死亡率的相关因素包括脓毒症/感染性休克(aOR 11.60;95%可信区间 4.66-28.82)、内科住院(aOR 4.67;95%可信区间 1.81-12.06)、中央静脉导管(aOR 3.78;95%可信区间 1.50-9.57)和 XDR-PA 感染(aOR 2.73;95%可信区间 1.05-7.08)。

结论

XDR-PA 感染的流行率占医院获得性铜绿假单胞菌感染的近四分之一,死亡率更高。当怀疑 XDR-PA 感染时,应及时给予适当的经验性抗生素治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8456/5823452/e08a7a67fc6a/pone.0193431.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8456/5823452/e08a7a67fc6a/pone.0193431.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8456/5823452/e08a7a67fc6a/pone.0193431.g001.jpg

相似文献

1
Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections.广泛耐药铜绿假单胞菌感染的流行病学和危险因素。
PLoS One. 2018 Feb 22;13(2):e0193431. doi: 10.1371/journal.pone.0193431. eCollection 2018.
2
Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.广泛耐药铜绿假单胞菌:住院患者发生血流感染的风险。
Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2791-7. doi: 10.1007/s10096-012-1629-3. Epub 2012 May 4.
3
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.埃塞俄比亚东北部德西综合专科医院住院患者中不动杆菌和铜绿假单胞菌医院感染的耐药谱及相关因素。一项横断面研究。
PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021.
4
Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections.广泛耐药铜绿假单胞菌感染成年癌症患者的特征、风险因素和结局。
Infection. 2014 Aug;42(4):721-8. doi: 10.1007/s15010-014-0635-z. Epub 2014 Jun 10.
5
An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.铜绿假单胞菌医院获得性肺炎的国际多中心回顾性研究:多重耐药性的影响
Crit Care. 2015 May 6;19(1):219. doi: 10.1186/s13054-015-0926-5.
6
Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.广泛耐药铜绿假单胞菌定植和感染的流行情况及相关危险因素:系统评价。
Expert Rev Anti Infect Ther. 2015;13(9):1159-70. doi: 10.1586/14787210.2015.1064310. Epub 2015 Jul 7.
7
Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.铜绿假单胞菌所致重症监护病房获得性肺炎(包括和不包括多重耐药)。
J Infect. 2017 Feb;74(2):142-152. doi: 10.1016/j.jinf.2016.11.008. Epub 2016 Nov 16.
8
Risk factors for hospitalized patients with resistant or multidrug-resistant infections: a systematic review and meta-analysis.住院患者耐多药或多重耐药感染的危险因素:系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2018 Jul 4;7:79. doi: 10.1186/s13756-018-0370-9. eCollection 2018.
9
Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia.影响菌血症性肺炎患者预后的铜绿假单胞菌的临床和细菌特征。
Int J Antimicrob Agents. 2021 Dec;58(6):106450. doi: 10.1016/j.ijantimicag.2021.106450. Epub 2021 Oct 10.
10
Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.铜绿假单胞菌抗生素耐药性的流行病学。对经验性和确定性治疗的影响。
Rev Esp Quimioter. 2017 Sep;30 Suppl 1:8-12.

引用本文的文献

1
Variable Efficacy of Delafloxacin on Multidrug-Resistant and the Detection of Delafloxacin Resistance Determinants.达氟沙星对多重耐药菌的疗效差异及达氟沙星耐药决定因素的检测
Antibiotics (Basel). 2025 May 25;14(6):542. doi: 10.3390/antibiotics14060542.
2
Multidrug-resistant and its coexistence with β-lactamases at a tertiary care hospital in a low-resource setting: a cross-sectional study with an association of risk factors.资源匮乏地区一家三级护理医院的多重耐药性及其与β-内酰胺酶的共存:一项危险因素关联的横断面研究
Ther Adv Infect Dis. 2025 Jun 18;12:20499361251345920. doi: 10.1177/20499361251345920. eCollection 2025 Jan-Dec.
3

本文引用的文献

1
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.哥伦比亚一家医院中耐碳青霉烯类铜绿假单胞菌所致医院获得性菌血症的危险因素
Biomedica. 2016 Feb 23;36(0):69-77. doi: 10.7705/biomedica.v36i2.2784.
2
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.与医疗保健相关感染有关的耐抗菌性病原体:2011 - 2014年向疾病控制与预防中心国家医疗保健安全网络报告的数据摘要
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1288-1301. doi: 10.1017/ice.2016.174. Epub 2016 Aug 30.
3
The Role of OXA-101 and OXA-573 in Extensively Drug-Resistant/ Pan Drug-Resistant (XDR/PDR) Resistance to Ceftazidime-Avibactam.
OXA-101和OXA-573在广泛耐药/泛耐药(XDR/PDR)菌对头孢他啶-阿维巴坦耐药中的作用
Infect Drug Resist. 2025 May 16;18:2547-2555. doi: 10.2147/IDR.S506452. eCollection 2025.
4
Antimicrobial Resistance and Mortality in Carbapenem-Resistant Infections in Southern Thailand.泰国南部耐碳青霉烯类感染中的抗菌药物耐药性与死亡率
Antibiotics (Basel). 2025 Mar 19;14(3):322. doi: 10.3390/antibiotics14030322.
5
Multidrug resistance of : do virulence properties impact on resistance patterns?多重耐药性:毒力特性是否会影响耐药模式?
Front Microbiol. 2025 Feb 5;16:1508941. doi: 10.3389/fmicb.2025.1508941. eCollection 2025.
6
Difficult-to-Treat Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal.重症患者难治性感染:综述与治疗建议
Antibiotics (Basel). 2025 Feb 11;14(2):178. doi: 10.3390/antibiotics14020178.
7
Risk Factors and Outcomes of Multidrug-resistant in Kelantan, Malaysia: A Multicenter Case-control Study.马来西亚吉兰丹州耐多药的危险因素及结局:一项多中心病例对照研究
Saudi J Med Med Sci. 2025 Jan-Mar;13(1):18-25. doi: 10.4103/sjmms.sjmms_429_24. Epub 2025 Jan 11.
8
Occurrence of Plasmid-Mediated Quinolone Resistance and Carbapenemase-Encoding Genes in Isolates from Nosocomial Patients in Aguascalientes, Mexico.墨西哥阿瓜斯卡连特斯医院患者分离株中质粒介导的喹诺酮耐药性和碳青霉烯酶编码基因的出现情况
Pathogens. 2024 Nov 13;13(11):992. doi: 10.3390/pathogens13110992.
9
Characterization and genetic analysis of extensively drug-resistant hospital acquired Pseudomonas aeruginosa isolates.广泛耐药医院获得性铜绿假单胞菌分离株的特征和遗传分析。
BMC Microbiol. 2024 Jun 26;24(1):225. doi: 10.1186/s12866-024-03321-5.
10
Sepsis-Related Lung Injury and the Complication of Extrapulmonary Pneumococcal Pneumonia.脓毒症相关肺损伤及肺外肺炎链球菌肺炎并发症
Diseases. 2024 Apr 3;12(4):72. doi: 10.3390/diseases12040072.
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.
黏菌素与多黏菌素联合对抗铜绿假单胞菌:剖析协同杀灭及耐药性预防的时间进程
J Antimicrob Chemother. 2015 May;70(5):1434-42. doi: 10.1093/jac/dku567. Epub 2015 Feb 23.
4
Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study.血液科患者群体中耐多药铜绿假单胞菌医院定植的临床及治疗相关危险因素:一项配对病例对照研究
BMC Infect Dis. 2014 Dec 10;14:650. doi: 10.1186/s12879-014-0650-9.
5
International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module.国际医院感染控制联盟(INICC)报告,2007 - 2012年43个国家的数据总结。器械相关模块。
Am J Infect Control. 2014 Sep;42(9):942-56. doi: 10.1016/j.ajic.2014.05.029.
6
Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit.泰国北部一所三级护理大学综合外科重症监护病房呼吸机相关性细菌性肺炎的微生物学、耐药模式和死亡率的危险因素。
Infect Drug Resist. 2014 Aug 16;7:203-10. doi: 10.2147/IDR.S67267. eCollection 2014.
7
Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients.广泛耐药铜绿假单胞菌菌血症于实体器官移植受者。
Transplantation. 2015 Mar;99(3):616-22. doi: 10.1097/TP.0000000000000366.
8
Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections.广泛耐药铜绿假单胞菌感染成年癌症患者的特征、风险因素和结局。
Infection. 2014 Aug;42(4):721-8. doi: 10.1007/s15010-014-0635-z. Epub 2014 Jun 10.
9
Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies.联合抗生素治疗与单药治疗铜绿假单胞菌菌血症的比较:回顾性和前瞻性研究的荟萃分析。
Int J Antimicrob Agents. 2013 Dec;42(6):492-6. doi: 10.1016/j.ijantimicag.2013.09.002. Epub 2013 Oct 1.
10
Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems.系统评价和体外协同作用的多粘菌素和碳青霉烯类抗生素的荟萃分析。
Antimicrob Agents Chemother. 2013 Oct;57(10):5104-11. doi: 10.1128/AAC.01230-13. Epub 2013 Aug 5.